Development of sporozoite vaccines
- PMID: 6084251
- DOI: 10.1098/rstb.1984.0113
Development of sporozoite vaccines
Abstract
Protective immunity against malaria has been achieved in hosts ranging from birds to man by repeated inoculation of irradiated sporozoites. The main antigens involved in protective immunity to sporozoites are the circumsporozoite (CS) proteins, which are part of a family of proteins, covering the whole surface membrane of the parasite, and which have similar physico-chemical and antigenic properties. Monovalent fragments of monoclonal antibodies to CS proteins neutralize sporozoite infectivity. All monoclonal antibodies recognize a single immunodominant region within the various CS proteins, and this region contains repetitive epitopes. The recurrent immunodominant epitope of the CS protein of P. knowlesi has been identified, and shown to consist of 12 tandemly repeated subunits of 12 amino acids. The dimer of the dodecapeptide was coupled to protein carriers, emulsified in Freund's complete adjuvant, and injected into rodents and monkeys. All animals made anti-peptide antibodies, and most of the antisera reacted with P. knowlesi CS protein.
Similar articles
-
Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites.Ciba Found Symp. 1986;119:150-63. doi: 10.1002/9780470513286.ch9. Ciba Found Symp. 1986. PMID: 2426050 Review.
-
Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.Science. 1985 Jun 21;228(4706):1436-40. doi: 10.1126/science.2409595. Science. 1985. PMID: 2409595
-
Structure of an immunodominant epitope of the circumsporozoite surface protein of Plasmodium knowlesi.Biochemistry. 1984 Nov 6;23(23):5665-70. doi: 10.1021/bi00318a043. Biochemistry. 1984. PMID: 6210107
-
Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.J Exp Med. 1983 Jun 1;157(6):1947-57. doi: 10.1084/jem.157.6.1947. J Exp Med. 1983. PMID: 6189951 Free PMC article.
-
Protective antigens of rodent and human bloodstage malaria.Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):171-7. doi: 10.1098/rstb.1984.0117. Philos Trans R Soc Lond B Biol Sci. 1984. PMID: 6151681 Review.
Cited by
-
Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.Cell Microbiol. 2016 Dec;18(12):1739-1750. doi: 10.1111/cmi.12608. Epub 2016 May 27. Cell Microbiol. 2016. PMID: 27130708 Free PMC article.
-
Immunogenicity, Efficacy, and Safety of a Novel Synthetic Microparticle Pre-Erythrocytic Malaria Vaccine in Multiple Host Species.Vaccines (Basel). 2023 Nov 30;11(12):1789. doi: 10.3390/vaccines11121789. Vaccines (Basel). 2023. PMID: 38140193 Free PMC article.
-
Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.Malar J. 2014 Apr 5;13:136. doi: 10.1186/1475-2875-13-136. Malar J. 2014. PMID: 24708526 Free PMC article.
-
Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11.Elife. 2020 Nov 30;9:e59018. doi: 10.7554/eLife.59018. Elife. 2020. PMID: 33253113 Free PMC article.
-
Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts.Sci Adv. 2018 Oct 10;4(10):eaau8529. doi: 10.1126/sciadv.aau8529. eCollection 2018 Oct. Sci Adv. 2018. PMID: 30324137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical